| 2019 | | A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression | 박상면, 조은혜, 주일로, 최동주 |
| 2018 | | A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3 | 조은혜, 최동주 |
| 2018 | | A Parkinson's disease gene, DJ-1, repairs brain injury through Sox9 stabilization and astrogliosis | 김병곤, 박상면, 조은혜, 주일로, 최동주 |
| 2013 | | A ratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes. | 조은혜 |
| 2015 | | Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease. | 조은혜 |
| 2024 | | Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease | 김동규, 김수정, 박상면, 우현구 |
| 2015 | | Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease. | 박상면, 조은혜, 주일로, 차선희 |
| 2020 | | Molecular events underlying the cell-to-cell transmission of alpha-synuclein | 박상면, 박수진 |
| 2017 | | Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease | 박상면 |
| 2021 | | Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment | 박상면 |
| 2022 | | Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein | 김수정, 박상면, 박선아, 진우람 |
| 2009 | | On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft. | 박상면, 주일로 |
| 2019 | | Parkinson's disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes | 김현미, 박상면, 이지훈, 조은혜, 주일로 |
| 2018 | | Prion-like Propagation of alpha-Synuclein Is Regulated by the FcgammaRIIB-SHP-1/2 Signaling Pathway in Neurons | 박상면, 주일로 |
| 2013 | | Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease. | 박상면 |
| 2012 | | Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease | 김광수, 박상면, 주일로 |
| 2021 | | Small heterodimer partner (SHP) aggravates ER stress in Parkinson’s disease-linked LRRK2 mutant astrocyte by regulating XBP1 SUMOylation | 이지훈, 조은혜, 주일로 |
| 1998 | | The cDNA cloning and ontogeny of mouse alpha-synuclein. | 곽병주, 조은혜 |
| 2020 | | The dual role of c-src in cell-to-cell transmission of alpha-synuclein | 박상면, 조은혜, 주일로, 최유리 |
| 2022 | | Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease | 박상면 |
| 2002 | | Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia. | 김승업, 이용범, 조경기, 조은혜, 진병관 |
